Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry
Rationale To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine. Methods The procedure involved the e...
Saved in:
Published in | Rapid communications in mass spectrometry Vol. 38; no. 17; pp. 1 - 1593 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
15.09.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rationale
To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.
Methods
The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid‐phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed‐phase column and analyzed using liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.
Results
The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.
Conclusions
We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub‐ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full‐scan mode. |
---|---|
AbstractList | To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.
The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid-phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed-phase column and analyzed using liquid chromatography/high-resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.
The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.
We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub-ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full-scan mode. Rationale To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine. Methods The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid‐phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed‐phase column and analyzed using liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run. Results The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples. Conclusions We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub‐ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full‐scan mode. To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.RATIONALETo uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid-phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed-phase column and analyzed using liquid chromatography/high-resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.METHODSThe procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid-phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed-phase column and analyzed using liquid chromatography/high-resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.RESULTSThe method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub-ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full-scan mode.CONCLUSIONSWe have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub-ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full-scan mode. RationaleTo uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.MethodsThe procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid‐phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed‐phase column and analyzed using liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.ResultsThe method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.ConclusionsWe have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub‐ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full‐scan mode. |
Author | Uchida, Taiga Kisugi, Takaya Ishii, Hideaki Yamada, Masayuki Leung, Gary Ngai‐Wa Kinoshita, Kenji |
Author_xml | – sequence: 1 givenname: Taiga orcidid: 0000-0001-8280-2602 surname: Uchida fullname: Uchida, Taiga email: t-uchida@lrc.or.jp organization: Laboratory of Racing Chemistry – sequence: 2 givenname: Takaya surname: Kisugi fullname: Kisugi, Takaya email: t-kisugi@lrc.or.jp organization: Laboratory of Racing Chemistry – sequence: 3 givenname: Hideaki orcidid: 0000-0002-6850-1894 surname: Ishii fullname: Ishii, Hideaki organization: Laboratory of Racing Chemistry – sequence: 4 givenname: Masayuki surname: Yamada fullname: Yamada, Masayuki organization: Laboratory of Racing Chemistry – sequence: 5 givenname: Kenji surname: Kinoshita fullname: Kinoshita, Kenji organization: Laboratory of Racing Chemistry – sequence: 6 givenname: Gary Ngai‐Wa orcidid: 0000-0002-6949-5721 surname: Leung fullname: Leung, Gary Ngai‐Wa organization: Laboratory of Racing Chemistry |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38945695$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1q3DAQgEVJaTZpoU9QBL304mRkW7J1bJf-QUqgtGejyOO1giU5kpWytz5CD33CPkm1u0kKhVw0MHyjb35OyJHzDgl5yeCMAZTnQdsz2XLxhKwYyKaAsmJHZAWSs6Jmsj0mJzFeAzDGS3hGjqtW1lxIviK_3wWv-j8_f8UZ9RKSpcr1NKKLZjG3SKMOiM64DfUDtT4gXUblaLYC1d7OPrk-UuMo3iTjkKawf-OuYjI511M9Bm_V4jdBzeP2fDSbMfsCRj-lxXhHrYqRHvze4hK2z8nTQU0RX9zFU_L9w_tv60_FxeXHz-u3F4WuGIhCNqzOI0LfCKh0v1uAwoENjWhaAXyf1C2WvC6bWmnBmBRClS2XPbsqoapOyZvDv3PwNwnj0lkTNU6TcuhT7CpoalZx4E1GX_-HXvsUXO4uU7JkkI11pl7dUenKYt_NwVgVtt39vv8ZdfAxBhweEAbd7pRdPmW3mySjxQH9YSbcPsp1X9df9vxfTRChfQ |
Cites_doi | 10.1002/dta.2896 10.1016/j.chroma.2017.10.043 10.1016/j.chroma.2014.05.010 10.1007/s00216‐012‐5972‐0 10.1016/j.aca.2017.07.005 10.1016/j.jchromb.2014.03.018 10.1016/j.chroma.2016.11.032 10.1016/j.jchromb.2015.06.020 10.1002/dta.1395 10.1039/c2an15662h 10.1093/jat/bku095 10.1007/s00216‐012‐6697‐9 10.1007/s00216‐010‐3455‐8 10.1002/dta.1737 10.1016/j.aca.2011.01.006 10.1021/ac070135o 10.1039/d0ay02297g 10.1002/dta.2671 10.1016/j.jchromb.2013.10.008 10.1002/dta.2880 10.1002/dta.2191 10.1016/j.ijms.2012.06.009 10.1002/dta.2892 10.1002/dta.3544 10.1002/dta.3353 10.1002/rcm.3712 10.1021/ac801234f 10.1002/dta.1719 |
ContentType | Journal Article |
Copyright | 2024 John Wiley & Sons Ltd. 2024 John Wiley & Sons, Ltd. |
Copyright_xml | – notice: 2024 John Wiley & Sons Ltd. – notice: 2024 John Wiley & Sons, Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7SR 7U5 8BQ 8FD JG9 JQ2 L7M 7X8 |
DOI | 10.1002/rcm.9856 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Engineered Materials Abstracts Solid State and Superconductivity Abstracts METADEX Technology Research Database Materials Research Database ProQuest Computer Science Collection Advanced Technologies Database with Aerospace MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Engineered Materials Abstracts Technology Research Database ProQuest Computer Science Collection Solid State and Superconductivity Abstracts Advanced Technologies Database with Aerospace METADEX MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Materials Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1097-0231 |
EndPage | 1593 |
ExternalDocumentID | 38945695 10_1002_rcm_9856 RCM9856 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Japan Racing Association |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHQN AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCZN ACGFS ACIWK ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIDQK AIDYY AITYG AIURR AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AQPKS ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LH5 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR RNS ROL RX1 RYL SAMSI SUPJJ TN5 UB1 V2E W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRJ WXSBR WYISQ XG1 XPP XV2 ZCG ZZTAW ~02 ~IA ~WT AAYXX CITATION AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE CGR CUY CVF ECM EIF NPM RWI WRC 7SR 7U5 8BQ 8FD JG9 JQ2 L7M 7X8 |
ID | FETCH-LOGICAL-c3106-97140950d7603cd9856aef1f7678605603cdc8e254274ac611966a2859d1b2033 |
IEDL.DBID | DR2 |
ISSN | 0951-4198 1097-0231 |
IngestDate | Thu Jul 10 21:35:34 EDT 2025 Fri Jul 25 12:24:11 EDT 2025 Wed Feb 19 02:06:22 EST 2025 Wed Aug 27 16:40:56 EDT 2025 Sun Jul 06 04:45:32 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 17 |
Language | English |
License | 2024 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3106-97140950d7603cd9856aef1f7678605603cdc8e254274ac611966a2859d1b2033 |
Notes | Taiga Uchida and Takaya Kisugi have contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6850-1894 0000-0002-6949-5721 0000-0001-8280-2602 |
PMID | 38945695 |
PQID | 3092108604 |
PQPubID | 1016428 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_3074135057 proquest_journals_3092108604 pubmed_primary_38945695 crossref_primary_10_1002_rcm_9856 wiley_primary_10_1002_rcm_9856_RCM9856 |
PublicationCentury | 2000 |
PublicationDate | 2024-09-15 |
PublicationDateYYYYMMDD | 2024-09-15 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bognor Regis |
PublicationSubtitle | RCM |
PublicationTitle | Rapid communications in mass spectrometry |
PublicationTitleAlternate | Rapid Commun Mass Spectrom |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2014; 958 2013; 405 2019; 11 2013; 941 2017; 1526 2020; 12 2024; 16 2013; 5 2012; 403 2015; 7 2007; 79 2017; 9 2021; 13 2012; 325‐327 2015; 998‐999 2011; 700 2023 2010; 396 2014; 38 2016; 1478 2022; 14 2008; 22 2014; 1357 2012; 137 2017; 985 2008; 80 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_12_1 e_1_2_8_30_1 |
References_xml | – volume: 1526 start-page: 1 year: 2017 end-page: 12 article-title: Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry‐based metabolomics: where do we stand? publication-title: J Chromatogr A – volume: 396 start-page: 2513 issue: 7 year: 2010 end-page: 2521 article-title: Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol‐epoetin beta in equine plasma by nano‐liquid chromatography‐tandem mass spectrometry publication-title: Anal Bioanal Chem – volume: 79 start-page: 4627 issue: 12 year: 2007 end-page: 4635 article-title: LC‐MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma publication-title: Anal Chem – volume: 12 start-page: 1274 issue: 9 year: 2020 end-page: 1286 article-title: Detection of bioactive peptides including gonadotrophin‐releasing factors (GnRHs) in horse urine using ultra‐high performance liquid chromatography‐high resolution mass spectrometry (UHPLC/HRMS) publication-title: Drug Test Anal – volume: 941 start-page: 69 year: 2013 end-page: 80 article-title: A generic screening methodology for horse doping control by LC‐TOF‐MS, GC‐HRMS and GC‐MS publication-title: J Chromatogr B Analyt Technol Biomed Life Sci – volume: 38 start-page: 536 issue: 8 year: 2014 end-page: 540 article-title: Equine total carbon dioxide testing in Illinois in 2012 publication-title: J Anal Toxicol – volume: 11 start-page: 1308 issue: 9 year: 2019 end-page: 1325 article-title: A comprehensive approach to detecting multitudinous bioactive peptides in equine plasma and urine using hydrophilic interaction liquid chromatography coupled to high resolution mass spectrometry publication-title: Drug Test Anal – volume: 325‐327 start-page: 80 year: 2012 end-page: 85 article-title: Orbitrap mass spectrometry with resolving powers above 1,000,000 publication-title: International Journal of Mass Spectrometry – volume: 12 start-page: 1452 issue: 10 year: 2020 end-page: 1461 article-title: An innovative derivatization‐free IC‐MS/MS method for the detection of bisphosphonates in horse plasma publication-title: Drug Test Anal – volume: 80 start-page: 8340 issue: 21 year: 2008 end-page: 8347 article-title: Identification of recombinant equine growth hormone in horse plasma by LC‐MS/MS: a confirmatory analysis in doping control publication-title: Anal Chem – volume: 1357 start-page: 36 year: 2014 end-page: 52 article-title: Core‐shell particles: preparation, fundamentals and applications in high performance liquid chromatography publication-title: J Chromatogr A – volume: 7 start-page: 619 issue: 7 year: 2015 end-page: 625 article-title: Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horses publication-title: Drug Test Anal – volume: 5 start-page: 509 issue: 7 year: 2013 end-page: 528 article-title: High resolution accurate mass screening of prohibited substances in equine plasma using liquid chromatography—orbitrap mass spectrometry publication-title: Drug Test Anal – volume: 13 start-page: 1565 issue: 13 year: 2021 end-page: 1575 article-title: Use of high resolution/accurate mass full scan/data‐dependent acquisition for targeted/non‐targeted screening in equine doping control publication-title: Anal Methods – volume: 1478 start-page: 35 year: 2016 end-page: 42 article-title: Simultaneous detection of recombinant growth hormones in equine plasma by liquid chromatography/high‐resolution tandem mass spectrometry for doping control publication-title: J Chromatogr A – volume: 958 start-page: 108 year: 2014 end-page: 116 article-title: HPLC/ESI‐MS(n) method for non‐amino bisphosphonates: application to the detection of tiludronate in equine plasma publication-title: J Chromatogr B Analyt Technol Biomed Life Sci – volume: 16 start-page: 406 issue: 4 year: 2024 end-page: 419 article-title: Detection of doping peptides and basic drugs in equine urine using liquid chromatography‐mass spectrometry publication-title: Drug Test Anal – volume: 14 start-page: 1724 issue: 10 year: 2022 end-page: 1731 article-title: A fully automated method to quantitate total carbon dioxide in equine plasma by headspace GCMS publication-title: Drug Test Anal – volume: 998‐999 start-page: 1 year: 2015 end-page: 7 article-title: Liquid chromatography‐mass spectrometry analysis of five bisphosphonates in equine urine and plasma publication-title: J Chromatogr B Analyt Technol Biomed Life Sci – volume: 12 start-page: 1462 issue: 10 year: 2020 end-page: 1469 article-title: Doping control analysis of total arsenic in equine plasma publication-title: Drug Test Anal – volume: 403 start-page: 1619 issue: 6 year: 2012 end-page: 1628 article-title: Detection of recombinant human EPO administered to horses using MAIIA lateral flow isoform test publication-title: Anal Bioanal Chem – volume: 22 start-page: 3130 issue: 20 year: 2008 end-page: 3136 article-title: Direct determination of recombinant bovine somatotropin in plasma from a treated goat by liquid chromatography/high‐resolution mass spectrometry publication-title: Rapid Commun Mass Spectrom – year: 2023 – volume: 985 start-page: 79 year: 2017 end-page: 90 article-title: Comprehensive solid‐phase extraction of multitudinous bioactive peptides from equine plasma and urine for doping detection publication-title: Anal Chim Acta – volume: 9 start-page: 1400 issue: 9 year: 2017 end-page: 1406 article-title: Interlaboratory trial for the measurement of total cobalt in equine urine and plasma by ICP‐MS publication-title: Drug Test Anal – volume: 700 start-page: 126 issue: 1–2 year: 2011 end-page: 136 article-title: Use of benchtop exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control publication-title: Anal Chim Acta – volume: 405 start-page: 2595 issue: 8 year: 2013 end-page: 2606 article-title: Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography‐mass spectrometry publication-title: Anal Bioanal Chem – volume: 137 start-page: 2445 issue: 10 year: 2012 end-page: 2453 article-title: A new analytical method based on anti‐EPO monolith column and LC‐FAIMS‐MS/MS for the detection of rHuEPOs in horse plasma and urine samples publication-title: Analyst – volume: 7 start-page: 21 issue: 1 year: 2015 end-page: 30 article-title: Controlling the misuse of cobalt in horses publication-title: Drug Test Anal – ident: e_1_2_8_22_1 doi: 10.1002/dta.2896 – ident: e_1_2_8_3_1 – ident: e_1_2_8_25_1 doi: 10.1016/j.chroma.2017.10.043 – ident: e_1_2_8_31_1 doi: 10.1016/j.chroma.2014.05.010 – ident: e_1_2_8_14_1 doi: 10.1007/s00216‐012‐5972‐0 – ident: e_1_2_8_8_1 doi: 10.1016/j.aca.2017.07.005 – ident: e_1_2_8_32_1 – ident: e_1_2_8_4_1 doi: 10.1016/j.jchromb.2014.03.018 – ident: e_1_2_8_18_1 doi: 10.1016/j.chroma.2016.11.032 – ident: e_1_2_8_5_1 doi: 10.1016/j.jchromb.2015.06.020 – ident: e_1_2_8_2_1 – ident: e_1_2_8_28_1 doi: 10.1002/dta.1395 – ident: e_1_2_8_15_1 doi: 10.1039/c2an15662h – ident: e_1_2_8_23_1 doi: 10.1093/jat/bku095 – ident: e_1_2_8_7_1 doi: 10.1007/s00216‐012‐6697‐9 – ident: e_1_2_8_13_1 doi: 10.1007/s00216‐010‐3455‐8 – ident: e_1_2_8_19_1 doi: 10.1002/dta.1737 – ident: e_1_2_8_27_1 doi: 10.1016/j.aca.2011.01.006 – ident: e_1_2_8_12_1 doi: 10.1021/ac070135o – ident: e_1_2_8_30_1 doi: 10.1039/d0ay02297g – ident: e_1_2_8_9_1 doi: 10.1002/dta.2671 – ident: e_1_2_8_29_1 doi: 10.1016/j.jchromb.2013.10.008 – ident: e_1_2_8_10_1 doi: 10.1002/dta.2880 – ident: e_1_2_8_21_1 doi: 10.1002/dta.2191 – ident: e_1_2_8_26_1 doi: 10.1016/j.ijms.2012.06.009 – ident: e_1_2_8_6_1 doi: 10.1002/dta.2892 – ident: e_1_2_8_11_1 doi: 10.1002/dta.3544 – ident: e_1_2_8_24_1 doi: 10.1002/dta.3353 – ident: e_1_2_8_17_1 doi: 10.1002/rcm.3712 – ident: e_1_2_8_16_1 doi: 10.1021/ac801234f – ident: e_1_2_8_20_1 doi: 10.1002/dta.1719 |
SSID | ssj0011520 |
Score | 2.4367769 |
Snippet | Rationale
To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive... To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening... RationaleTo uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1 |
SubjectTerms | Animals Chromatography Chromatography, Liquid - methods Column chromatography Doping in Sports - prevention & control Horses - urine Limit of Detection Liquid chromatography Mass spectrometry Mass Spectrometry - methods Negative ions Reproducibility of Results Scientific imaging Screening Solid Phase Extraction - methods Substance Abuse Detection - methods Substance Abuse Detection - veterinary Target detection Urine |
Title | Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Frcm.9856 https://www.ncbi.nlm.nih.gov/pubmed/38945695 https://www.proquest.com/docview/3092108604 https://www.proquest.com/docview/3074135057 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iRS--H-uLEcRbd9M0aZujLIoIehAFwUNJmxRFt9Vd9-LJn-DBX-gvcaaPFRVBvLSQpp2888108g1je3kWxjh0rKdMGnvSt8pLI809p4QMuNM2l3R2-PQsPL6UJ1fqqvGqpLMwNT_ExOBGM6Nar2mCm3TU-yQNHWaDro4VsW2TqxbhofMJcxTinJqRkaLIS1SsW95ZLnrti193oh_w8itarbabo3l23Ra09jK5646f0m72_I3D8X81WWBzDQqFg3rYLLIpVyyxmX4b_G2ZvaF6buz7y2t1EnM4HoApLIzI253WR8DFBhVg3PagzIF8dYFM8EBmfCAvdQrWNILbAtzjGMsHZNPHKxkm4P4W0yxkN8MS4XJDmd0j3mSUh9p_MxlggLgeavnlwGGxVtjl0eFF_9hrAjh4GaLG0NPEBqgVt1HIg8xSHY3L_TzCHRLVqCoxix3qqKgbmyz0cTkIDVHqWT8VPAhW2XRRFm6dgZFGqFzYOMqV9I2JuUhlFCkteG6V1R2223Zm8lDzdCQ1I7NIsH0Tkt1hW20vJ81MHSUB14KiTXGJn5g8xtamHyemcOWY8iDuCkiV67C1enRMhCDgQwyqVYftV338q_TkvH9K942_ZtxkswIRFDmn-GqLTWNnu21EQE_pTjXWPwBFVAWu |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB5V5VAu_P8ECgwScHOy3uza3gMHSKlS2vRQtVJvZu1diwpig9MIwYlH4MBb8Co8BU_CjH-CCkLi0gOXRLKdjDU7M_vN7uw3AI-KPErIdFygbZYEKnQ6yGIjAq-lGgtvXKH47PBsP5oeqZfH-ngNvvVnYVp-iNWCG3tGE6_ZwXlBevSLNbTO50OT6KirqNz1Hz9QvrZ4urNFg_tYyu0Xh5Np0LUUCHLCMVFgmJ_OaOHiSIxzxz-3vgiLmGI2AfvmYp54ypooW7N5FJKBRpZJ3lyYScGrnxTvL3ADcSbq3zpYcVURsmo5ILlvvaJUvme6FXLUv-nZue8PQHsWHzcT3PZl-N6rpq1reTNcnmbD_NNvrJH_ie6uwKUOaOOz1jOuwpovr8HGpO9vdx2-Pq8r6358_tIcNq2Xc7SlwwUX9PMUgBRPKcenmR2rArkcGXmXAXmnArkQn_tRLfCkRP9-SQpB3ragT157wbcndM1h_rquKCPoWMFHTA1N8mrf-zvOKXXBVn419_RaN-DoXJRyE9bLqvS3Aa2yUhfSJXGhVWhtImSm4lgbKQqnnRnAw9560nctFUnakk7LlMYzZdkD2OzNKu2C0SIdCyO5oZZQ9Ber26Rt3huypa-W_AxByzFnqwO41ZrjSghhWoLZRg_gSWNUf5WeHkxm_H3nXx98ABvTw9leurezv3sXLkoCjFyLE-pNWKeB9_cI8J1m9xtHQ3h13tb5E4VmXoA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB5VRQIu_P8ECgwScHOy3uza3gMHSIhaSitUUak3s_auRQWxi9MIwYlH4MBT8Cq8BU_CjH-CCkLi0gOXRLKdjDU7M_vN7uw3AA-KPErIdFygbZYEKnQ6yGIjAq-lGgtvXKH47PDObrS5r54f6IM1-NafhWn5IVYLbuwZTbxmBz9yxegXaWidz4cm0VFXULntP36gdG3xeGtKY_tQytmzV5PNoOsoEOQEY6LAMD2d0cLFkRjnjn9ufREWMYVswvXNxTzxlDRRsmbzKCT7jCxzvLkwk4IXPyncn1GRMNwmYrq3oqoiYNVSQHLbekWZfE90K-Sof9OTU98fePYkPG7mt9lF-N5rpi1reTtcHmfD_NNvpJH_h-ouwYUOZuOT1i8uw5ovr8C5Sd_d7ip8fVpX1v34_KU5alov52hLhwsu5-cJACmaUoZP8zpWBXIxMvIeA_I-BXIZPnejWuBhif79kvSBvGlBn7zygu8O6ZrD_E1dUT7QcYKPmBia5NW-93acU-KCrfxq7um1rsH-qSjlOqyXVelvAlplpS6kS-JCq9DaRMhMxbE2UhROOzOA-73xpEctEUnaUk7LlMYzZdkD2OitKu1C0SIdCyO5nZZQ9Ber26Rt3hmypa-W_AwByzHnqgO40VrjSgghWgLZRg_gUWNTf5We7k12-PvWvz54D86-nM7SF1u727fhvCS0yIU4od6AdRp3f4fQ3nF2t3EzhNenbZw_AfHhXS8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Broad-spectrum+and+sensitive+screening+of+more+than+1000+compounds+in+equine+urine+using+liquid+chromatography%2Fhigh-resolution+mass+spectrometry&rft.jtitle=Rapid+communications+in+mass+spectrometry&rft.au=Uchida%2C+Taiga&rft.au=Kisugi%2C+Takaya&rft.au=Ishii%2C+Hideaki&rft.au=Yamada%2C+Masayuki&rft.date=2024-09-15&rft.eissn=1097-0231&rft.volume=38&rft.issue=17&rft.spage=e9856&rft_id=info:doi/10.1002%2Frcm.9856&rft_id=info%3Apmid%2F38945695&rft.externalDocID=38945695 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-4198&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-4198&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-4198&client=summon |